Stoke Therapeutics
STOK
STOK
53 hedge funds and large institutions have $339M invested in Stoke Therapeutics in 2019 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
17% less capital invested
Capital invested by funds: $409M → $339M (-$70.4M)
Holders
53
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$20.8M | |
| 2 | +$16M | |
| 3 | +$16M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$12.9M |
| 5 |
Millennium Management
New York
|
+$4.05M |
Top Sellers
| 1 | -$7.29M | |
| 2 | -$5.82M | |
| 3 | -$5.77M | |
| 4 |
O
OrbiMed
New York
|
-$3.79M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.91M |